Literature DB >> 27141959

Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions.

Halil Yildiz1, Francis Zech1, Philippe Hainaut1.   

Abstract

BACKGROUND: Venous thromboembolism has been reported in association with cytomegalovirus (CMV) infection both in immunocompromised and immunocompetent patients. In this population, it is yet undetermined whether CMV alone provokes VTE or other predisposing conditions are involved.
MATERIALS AND METHODS: 1007 VTE patients consecutively recruited in one academic hospital were analyzed retrospectively in order to identify acute CMV infection. Acquired and inherited risk factors were screened. Only adults and immunocompetent patients were included.
RESULTS: Among 1007 consecutive VTE patients, we identified 10 patients with synchronous acute CMV infection. Patients with coexistent VTE and acute CMV infection were younger (37.5 years vs. 56.6 years; p = 0.0088) and exhibited a female predominance (90% vs. 56%; p = 0.026), in comparison to the whole cohort. Hereditary thrombophilia was identified in 9 out of 10 patients. Acquired risk factors for VTE like estrogens administration and pregnancy were equally prevalent in patients with and without CMV infection.
CONCLUSION: Acute CMV infection is a potential contributor to VTE whenever other prothrombotic conditions are required. This should help clinicians to privilege a limited duration of anticoagulant treatment like in other provoked VTE.

Entities:  

Keywords:  Cytomegalovirus infection; Superficial venous thrombosis; Thrombophilia; Venous thromboembolism

Mesh:

Year:  2016        PMID: 27141959     DOI: 10.1080/17843286.2016.1177265

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  6 in total

1.  Venous Thrombosis Secondary to Acute Cytomegalovirus Infection in an Immunocompetent Host: Consideration for New Screening Guidelines.

Authors:  Sam Ngu; Naureen Narula; Talha N Jilani; Alexander Bershadskiy
Journal:  Cureus       Date:  2018-06-05

2.  Pulmonary Embolism in a Young Immunocompetent Adult Infected with Cytomegalovirus. Are Novel Oral Anticoagulants an Efficient Alternative?

Authors:  Ioannis Bountouris; Demetrios Moris; Diamantis I Tsilimigras; George Laoutaris; Georgia Kritikou; Viktoria-Varvara Palla; Georgios Karaolanis
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

3.  Papaverine adjuvant therapy for microcirculatory disturbance in severe ulcerative colitis complicated with CMV infection: a case report.

Authors:  Yu Tian; Yue Zheng; Jinpei Dong; Jixin Zhang; Huahong Wang
Journal:  Clin J Gastroenterol       Date:  2019-04-03

4.  Genetic Predisposition of Anti-Cytomegalovirus Immunoglobulin G Levels and the Risk of 9 Cardiovascular Diseases.

Authors:  Jiang-Shan Tan; Jia-Meng Ren; Luyun Fan; Yuhao Wei; Song Hu; Sheng-Song Zhu; Yanmin Yang; Jun Cai
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

Review 5.  Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Giuseppe Nunnari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-18       Impact factor: 5.103

Review 6.  Elevated Risk of Venous Thromboembolism in People Living with HIV.

Authors:  Quan Zhang; Fei Peng; Meizhi Li; Qiong Yi; Wei Tang; Shangjie Wu
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.